Journal article

Publication year: 2020

Journal: Journal of Clinical Medicine

Volume number: 9

Issue number: 3

eISSN: 2077-0383

Open access status: Gold

DOI Link: https://doi.org/10.3390/jcm9030682

Publisher: MDPI

Abstract: 
Chronic lung diseases pose a tremendous global burden. At least one in four people suffer from severe pulmonary sequelae over the course of a lifetime. Despite substantial improvements in therapeutic interventions, persistent alleviation of clinical symptoms cannot be offered to most patients affected to date. Despite broad discrepancies in origins and pathomechanisms, the important disease entities all have in common the pulmonary inflammatory response which is central to lung injury and structural abnormalities. Mesenchymal stem cells (MSC) attract particular attention due to their broadly acting anti-inflammatory and regenerative properties. Plenty of preclinical studies provided congruent and convincing evidence that MSC have the therapeutic potential to alleviate lung injuries across ages. These include the disease entities bronchopulmonary dysplasia, asthma and the different forms of acute lung injury and chronic pulmonary diseases in adulthood. While clinical trials are so far restricted to pioneering trials on safety and feasibility, preclinical results point out possibilities to boost the therapeutic efficacy of MSC application and to take advantage of the MSC secretome. The presented review summarizes the most recent advances and highlights joint mechanisms of MSC action across disease entities which provide the basis to timely tackle this global disease burden.

Harvard Citation style: Behnke, J., Kremer, S., Shahzad, T., Chao, C., Boettcher-Friebertshaeuser, E., Morty, R., et al. (2020) MSC Based Therapies-New Perspectives for the Injured Lung, Journal of Clinical Medicine, 9(3), Article 682. https://doi.org/10.3390/jcm9030682

APA Citation style: Behnke, J., Kremer, S., Shahzad, T., Chao, C., Boettcher-Friebertshaeuser, E., Morty, R., Bellusci, S., & Ehrhardt, H. (2020). MSC Based Therapies-New Perspectives for the Injured Lung. Journal of Clinical Medicine. 9(3), Article 682. https://doi.org/10.3390/jcm9030682